**Abstract**

**Specific objective of the study**: We analyzed data to answer several questions: (1) How old were patients who first refilled their treatment medications used primarily for ADHD, regardless of the medication type? (2) What socio-demographic factors (e.g., age, gender, insurance type, place of living, hospital level, and specialist type) are associated with medication adherence? (3) What medical conditions, such as medication type and comorbid diagnosis, influence adherence?

**Methods used:** To identify the factors associated with ADHD medication adherence and persistence, we analyzed National Health Insurance data, which comprised continuously enrolled Korean National Medical Insurance children (6--18 years) with at least 2 ADHD prescription claims (January 2008--December 2011). We investigated the effects of age cohort, gender, insurance types, professions who prescribe the medication, regions, clinic types, presence of comorbidities, and medication types on adherence to the ADHD medication treatment during the treatment period.

**Summary of results**: The medication type \[Atomoxetine (OR=1.77, 1.59--1.97)\>ER-MPH (1.28, 1.17--1.39), OROS-MPH (OR=1.27, 1.17--1.39)\>IR-MPH (OR=0.84, 0.77--0.92)\], age 10--15 \[age 10--12 (OR=0.91, 0.85--0.97) and age 13--15 (OR=0.84, 0.79--0.90) vs age 16--18\], physician specialty \[psychiatrist (OR=1.36, 1.12--1.53) or pediatrician (OR=1.45, 1.23--1.71)\], treatment at a private clinic (OR=1.57, 1.51--1.63), and comorbid conditions (OR=1.30, 1.26--1.35) were associated with medication adherence during continuous treatment using a multivariate analysis. However, male gender and insurance type were not associated with the adherence rates.

**Conclusions reached:** We suggest that other factors, including the severity, family history, costs, types of comorbidity, and switching patterns, will be analyzed in future studies.
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